Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Close this folderAppendix: Electronic sources of information
View the documentFor general access to evidence
View the documentJournal articles
View the documentSystematic reviews
View the documentNational disease prevention and control, health promotion etc.
View the documentHealth technology assessment
View the documentClinical guidelines
View the documentFormularies/Essential medicines
View the documentRegulatory authorities
View the documentAdverse effects
View the documentInformation about/for patients
View the documentDrug promotion
View the documentNetworks and directories
View the documentISDB member bulletins
View the documentFeedback and evaluation form
 

Systematic reviews

The Cochrane Library

Database of systematic reviews.
http://www.cochrane.org

Access to The Cochrane Library is free to all in England, Wales, Ireland, Australia, Norway, Sweden, Finland and South Africa. Details of how to gain access can be found on the following web site:
http://www3.interscience.wiley.com/cgibin/mrwhome/106568753/DoYouAlreadyHaveAccess.html.

The publishers of the The Cochrane Library are piloting a scheme whereby editors of selected publications, including ISDB member bulletins, can receive complementary access to The Cochrane Library. Contact Alexa Dugan at adugan@wiley.co.uk giving your name, publication details, e-mail address and full postal address.

Clinical Evidence

Describes the best available evidence from systematic reviews, randomised controlled trials and observational studies where appropriate, and if there is no good evidence it says so.
http://www.clinicalevidence.com/ceweb/conditions/index.jsp

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014